Scientific and therapeutic advances in antiplatelet therapy

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Nature reviews. Drug discovery

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/nrd985PMID 12509756
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Benefit of Clopidogrel Over Aspirin Is Amplified in Patients With a History of Ischemic Events

  2004cited by this paper
• Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention: results of the Coronary Revascularization Using Integrilin and Single bolus Enoxaparin Study.

  2003cited by this paper
• Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus.

  2002cited by this paper
• Clopidogrel, but not abciximab, reduces platelet leukocyte conjugates and P‐selectin expression in a human ex vivo in vitro model

  2002cited by this paper
• Deposition of Platelet RANTES Triggering Monocyte Recruitment Requires P-Selectin and Is Involved in Neointima Formation After Arterial Injury

  2002cited by this paper
• Arp2/3 complex is required for actin polymerization during platelet shape change.

  2002cited by this paper
• Thrombin receptor antagonists; recent advances in PAR-1 antagonist development.

  2002cited by this paper
• Underuse of aspirin in a referral population with documented coronary artery disease.

  2002cited by this paper
• Efficacy and age-related effects of nitric oxide-releasing aspirin on experimental restenosis

  2002cited by this paper
• Attacked from within, blood thins

  2002cited by this paper
• Pepducin-based intervention of thrombin-receptor signaling and systemic platelet activation

  2002cited by this paper
• Functional Significance of Adenosine 5′-Diphosphate Receptor (P2Y12) in Platelet Activation Initiated by Binding of von Willebrand Factor to Platelet GP Ib&agr; Induced by Conditions of High Shear Rate

  2002cited by this paper
• Contact--How Platelets Touch von Willebrand Factor

  2002cited by this paper
• Functional Significance of Adenosine 5′-Diphosphate Receptor (P2Y12) in Platelet Activation Initiated by Binding of von Willebrand Factor to Platelet GP Ibα Induced by Conditions of High Shear Rate

  2002cited by this paper
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

  2002cited by this paper
• Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization.

  2002cited by this paper
• Effect of leptin on arterial thrombosis following vascular injury in mice.

  2002cited by this paper
• Role of ADP Receptor P2Y12 in Platelet Adhesion and Thrombus Formation in Flowing Blood

  2002cited by this paper
• Selective Inhibition of Protease-activated Receptor 4-dependent Platelet Activation by YD-3

  2002cited by this paper
• Inhibition of ADP-induced P-selectin Expression and Platelet-Leukocyte Conjugate Formation by Clopidogrel and the P2Y12 Receptor Antagonist AR-C69931MX but not Aspirin

  2002cited by this paper
• Acute coronary syndromes

  2002cited by this paper
• Protease-activated receptors 1 and 4 do not stimulate G(i) signaling pathways in the absence of secreted ADP and cause human platelet aggregation independently of G(i) signaling.

  2002cited by this paper
• Platelet Glycoprotein IIb/IIIa Inhibitors: Recognition of a Two-Edged Sword?

  2002cited by this paper
• CD40 Ligand Inhibits Endothelial Cell Migration by Increasing Production of Endothelial Reactive Oxygen Species

  2002cited by this paper
• A Critical Role of Platelet Adhesion in the Initiation of Atherosclerotic Lesion Formation

  2002cited by this paper
• Chronic treatment with nitric oxide-releasing aspirin reduces plasma low-density lipoprotein oxidation and oxidative stress, arterial oxidation-specific epitopes, and atherogenesis in hypercholesterolemic mice

  2002cited by this paper
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

  2002cited by this paper
• The Influence of Platelet Collagen Receptor Polymorphisms in Hemostasis and Thrombotic Disease

  2002cited by this paper
• Enoxaparin as Adjunctive Antithrombin Therapy for ST-Elevation Myocardial Infarction: Results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial

  2002cited by this paper
• Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.

  2002cited by this paper
• Aspirin for the Primary Prevention of Cardiovascular Events: A Summary of the Evidence for the U.S. Preventive Services Task Force

  2002cited by this paper
• Need to test the arterial inflammation hypothesis.

  2002cited by this paper
• Multi-year follow-up of abciximab therapy in three randomized, placebo-controlled trials of percutaneous coronary revascularization.

  2002cited by this paper
• Recombinant Soluble P-Selectin Glycoprotein Ligand-Ig (rPSGL-Ig) Attenuates Infarct Size and Myeloperoxidase Activity in a Canine Model of Ischemia-Reperfusion

  2002cited by this paper
• Structures of Glycoprotein Ibα and Its Complex with von Willebrand Factor A1 Domain

  2002cited by this paper
• Effects of the thromboxane synthetase inhibitor and receptor antagonist terbogrel in patients with primary pulmonary hypertension.

  2002cited by this paper
• Reversal of Thrombin-Induced Deactivation of CD39/ATPDase in Endothelial Cells by HMG-CoA Reductase Inhibition: Effects on Rho-GTPase and Adenosine Nucleotide Metabolism

  2002cited by this paper
• A new name in thrombosis, ADAMTS13

  2002cited by this paper
• Platelet-derived CD40L: the switch-hitting player of cardiovascular disease.

  2002cited by this paper
• Biomedicine. Contact--how platelets touch von Willebrand factor.

  2002cited by this paper
• Clopidogrel inhibits platelet adhesion and platelet-dependent mitogenesis in vascular smooth muscle cells.

  2002cited by this paper
• Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain.

  2002cited by this paper
• Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting.

  2002cited by this paper
• ADAMTS13 and TTP

  2002cited by this paper
• Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular Events

  2002cited by this paper
• Optimizing glycoprotein IIb/IIIa inhibition: lessons from recent randomized controlled trials

  2002cited by this paper
• Activation and inhibition of G protein-coupled receptors by cell-penetrating membrane-tethered peptides

  2002cited by this paper
• Aspirin for the Primary Prevention of Cardiovascular Events: Recommendation and Rationale

  2002cited by this paper
• Blockade of adenosine diphosphate receptors P2Y(12) and P2Y(1) is required to inhibit platelet aggregation in whole blood under flow.

  2001cited by this paper
• Activated platelets mediate inflammatory signaling by regulated interleukin 1β synthesis

  2001cited by this paper
• Dual antiplatelet therapy with clopidogrel and aspirin after carotid artery stenting.

  2001cited by this paper
• Effects of nitric oxide-releasing aspirin versus aspirin on restenosis in hypercholesterolemic mice

  2001cited by this paper
• Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial.

  2001cited by this paper
• CD40 Signaling and Plaque Instability

  2001cited by this paper
• Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis

  2001cited by this paper
• RANTES Deposition by Platelets Triggers Monocyte Arrest on Inflamed and Atherosclerotic Endothelium

  2001cited by this paper
• Benefit of Glycoprotein IIb/IIIa Inhibition in Patients With Acute Coronary Syndromes and Troponin T–Positive Status: The PARAGON-B Troponin T Substudy

  2001cited by this paper
• Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial.

  2001cited by this paper
• The ATP-Gated P2X1 Ion Channel Acts as a Positive Regulator of Platelet Responses to Collagen

  2001cited by this paper
• Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein.

  2001cited by this paper
• A Model of Platelet Aggregation Involving Multiple Interactions of Thrombospondin-1, Fibrinogen, and GPIIbIIIa Receptor*

  2001cited by this paper
• Production and characterization of saratin, an inhibitor of von Willebrand factor-dependent platelet adhesion to collagen.

  2001cited by this paper
• PlA2 Polymorphism of &bgr;3 Integrins Is Associated With Enhanced Thrombin Generation and Impaired Antithrombotic Action of Aspirin at the Site of Microvascular Injury

  2001cited by this paper
• Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization.

  2001cited by this paper
• The prothrombotic effects of leptin possible implications for the risk of cardiovascular disease in obesity.

  2001cited by this paper
• Platelet CD40 ligand (CD40L) – subcellular localization, regulation of expression, and inhibition by clopidogrel

  2001cited by this paper
• Platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention: the ESPRIT trial: a randomized controlled trial.

  2001cited by this paper
• Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials

  2001cited by this paper
• Profile and prevalence of aspirin resistance in patients with cardiovascular disease.

  2001cited by this paper
• For personal use. Only reproduce with permission from The Lancet Publishing Group. Late cardiopulmonary complication of ventriculo-atrial shunt

  2001cited by this paper
• Ligation of CD40 on Vascular Smooth Muscle Cells Mediates Loss of Interstitial Collagen via Matrix Metalloproteinase Activity

  2001cited by this paper
• The P2Y1 Receptor Antagonist Adenosine-2’,5’-Diphosphate Non-selectively Antagonizes the Platelet P2X1 Ion Channel

  2001cited by this paper
• Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial.

  2001cited by this paper
• Platelet Glycoprotein Ib&agr; HPA-2 Met/VNTR B Haplotype as a Genetic Predictor of Myocardial Infarction and Sudden Cardiac Death

  2001cited by this paper
• Antiplatelet and anticoagulant therapy in the secondary prevention of ischemic heart disease.

  2001cited by this paper
• Cardiovascular biology: Small cells, big issues

  2001cited by this paper
• Role of thrombin signalling in platelets in haemostasis and thrombosis

  2001cited by this paper
• Resistance to thromboembolism in PI3Kγ‐deficient mice

  2001cited by this paper
• Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study.

  2001cited by this paper
• Identification of the platelet ADP receptor targeted by antithrombotic drugs

  2001cited by this paper
• Aspirin use and all-cause mortality among patients being evaluated for known or suspected coronary artery disease: A propensity analysis.

  2001cited by this paper
• The Prothrombotic Effects of Leptin

  2001cited by this paper
• Single Nucleotide Polymorphisms in Multiple Novel Thrombospondin Genes May Be Associated With Familial Premature Myocardial Infarction

  2001cited by this paper
• A thrombin receptor function for platelet glycoprotein Ib-IX unmasked by cleavage of glycoprotein V.

  2001cited by this paper
• Cardiovascular biology: Platelets and proteases

  2001cited by this paper
• Common variations in platelet glycoproteins: pharmacogenomic implications.

  2001cited by this paper
• Soluble CD40L and Cardiovascular Risk in Women

  2001cited by this paper
• Abciximab Suppresses the Rise in Levels of Circulating Inflammatory Markers After Percutaneous Coronary Revascularization

  2001cited by this paper
• EFFECTS OF CLOPIDOGREL IN ADDITION TO ASPIRIN IN PATIENTS WITH ACUTE CORONARY SYNDROMES WITHOUT ST-SEGMENT ELEVATION

  2001cited by this paper
• Platelet glycoprotein Ibalpha HPA-2 Met/VNTR B haplotype as a genetic predictor of myocardial infarction and sudden cardiac death.

  2001cited by this paper
• Prevention of intimal hyperplasia with recombinant soluble P-selectin glycoprotein ligand-immunoglobulin in the porcine coronary artery balloon injury model.

  2001cited by this paper
• Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity.

  2001cited by this paper
• Increased Mortality With Oral Platelet Glycoprotein IIb/IIIa Antagonists: A Meta-Analysis of Phase III Multicenter Randomized Trials

  2001cited by this paper
• Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.

  2001cited by this paper
• Resistance to thromboembolism in PI3Kgamma-deficient mice.

  2001cited by this paper
• Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction.

  2001cited by this paper
• Platelet Glycoprotein IIb/IIIa Inhibitors Reduce Mortality in Diabetic Patients With Non–ST-Segment-Elevation Acute Coronary Syndromes

  2001cited by this paper
• Point-of-Care Measured Platelet Inhibition Correlates With a Reduced Risk of an Adverse Cardiac Event After Percutaneous Coronary Intervention: Results of the GOLD (AU-Assessing Ultegra) Multicenter Study

  2001cited by this paper
• Inflammation and thrombosis: the clot thickens.

  2001cited by this paper
• Cardiovascular biology. Small cells, big issues.

  2001cited by this paper

• Relationship between Aspirin Resistance and Gene Polymorphism in Chinese Patients with Cerebral Infarction: A Systematic Review and Meta-Analysis

  2026cites this paper
• Facilitating In-Stent Restenosis Research: A Novel Removable Stent Strut Model in Mice.

  2025cites this paper
• Study Design and Rationale of a Randomized Trial Comparing Aspirin–Sarpogrelate Combination Therapy with Aspirin Monotherapy: Effects on Blood Viscosity and Microcirculation in Cardiovascular Patients

  2025cites this paper
• Effect of 6-methyl-5-hepten-2-one (Sulcatone) on hemostasis parameters in SHR rats: In Silico, In Vitro, and In Vivo approaches

  2025cites this paper
• A review on recent advances of AI-integrated microfluidics for analytical and bioanalytical applications

  2024cites this paper
• Национальные клинические рекомендации по диагностике и лечению Ph-негативных миелопролиферативных новообразований (истинной полицитемии, эссенциальной тромбоцитемии, первичного миелофиброза) (редакция 2024 г.)

  2024cites this paper
• Contributions of the individual domains of αIIbβ3 integrin to its extension: Insights from multiscale modeling

  2024cites this paper
• Pharmacokinetics of aspirin: evaluating shortcomings in the literature

  2024cites this paper
• Differential Proteoglycan Expression in Atherosclerosis Alters Platelet Adhesion and Activation

  2024cites this paper
• Comprehensive multiparameter evaluation of platelet function using a highly sensitive membrane capacitance sensor.

  2023cites this paper
• Composition Counts: A Machine Learning View on Immunothrombosis using Quantitative Phase Imaging

  2023cites this paper
• Platelets: Physiology and Biochemistry

  2023cites this paper
• Antithrombotic therapy in patients with diabetes mellitus

  2023cites this paper
• Therapeutic management of ischemic stroke

  2023cites this paper
• Monitoring antiplatelet therapy: where are we now?

  2022cites this paper
• causes, clinical

  2022cites this paper
• Clinical pharmacology of antiplatelet drugs

  2022cites this paper
• Application of a Simple Microfluidic Chip Analysis Technology to Evaluate the Inhibitory Role of Protocatechuic Acid on Shear-Induced Platelet Aggregation

  2021cites this paper
• Pharmacodynamics and Pharmacokinetics of Stroke Therapy

  2021cites this paper
• Massive image-based single-cell profiling reveals high levels of circulating platelet aggregates in patients with COVID-19

  2021cites this paper
• Receptors | P2Y Receptors

  2021cites this paper
• The Role and Molecular Mechanism of P2Y12 Receptors in the Pathogenesis of Atherosclerotic Cardiovascular Diseases

  2021cites this paper
• Understanding microvascular thrombosis in COVID-19 via massive single-cell imaging of circulating platelets

  2021cites this paper
• Supplementation of Lipoic Acid, Zinc and Clopidogrel Reduces Mortality Rate and Incidence of Ventricular Arrhythmia in Experimental Myocardial Infarction

  2021cites this paper
• Capsaicin and Gut Microbiota in Health and Disease

  2020cites this paper
• Review on Health Benefits of Camel Urine: Therapeutics Effects and Potential Impact on Public Health Around East Hararghe District

  2020cites this paper
• Evolving Approaches to Antithrombotics in Stroke Prevention and Treatment

  2020cites this paper
• The Serine/Threonine Protein Phosphatase 2A (PP2A) Regulates Syk Activity in Human Platelets

  2020cites this paper
• Conformation-Specific Blockade of αIIbβ3 by a Non-RGD Peptide to Inhibit Platelet Activation without Causing Significant Bleeding and Thrombocytopenia

  2020cites this paper
• Antidiabetic, Antithrombin and Cytotoxic bioactive compounds in five cultivars of Piper betle L.

  2020cites this paper
• Separation-free spectrophotometric platforms for rapid assessment of combined antiplatelet therapy in complex matrices.

  2020cites this paper
• Development and validation of HPLC-UV method for quantitation of a new antithrombotic drug in rat plasma and its application to pharmacokinetic studies.

  2020cites this paper
• The cardioprotective properties and the involved mechanisms of NaoXinTong Capsule

  2019cites this paper
• Recent Advances and Computational Approaches in Peptide Drug discovery.

  2019cites this paper
• Caesalpinia Crista Seed Exhibits Strong Anticoagulant and Antiplatelet Activity

  2019cites this paper
• The Coagulation Cascade and its Therapeutic Modulation

  2019cites this paper
• Shear-Dependent Platelet Aggregation: Mechanisms and Therapeutic Opportunities

  2019cites this paper
• Novel Antiplatelet Therapies

  2019cites this paper
• Utility of in vitro and in vivo systems for studying the permeability of capsaicin and nonivamide through different intestinal regions

  2018cites this paper
• On the Role of Store-Operated Calcium Entry in Acute and Chronic Neurodegenerative Diseases

  2018cites this paper
• Фармакогенетика антитромботических препаратов: современное состояние проблемы

  2018cites this paper
• PHARMACOGENETICS OF ANTITHROMBOTIC DRUGS: STATUS UPDATE ON THE PROBLEM

  2018cites this paper
• EVALUATION OF ASPIRIN RESPONSIVENESS IN ESSENTIAL THROMBOCYTHEMIA PATIENTS

  2018cites this paper
• Clopidogrel Pharmacokinetics in Malaysian Population Groups: The Impact of Inter-Ethnic Variability

  2018cites this paper
• [P2X4, Ca2+ and CXCL5, a new pro-inflammatory trio].

  2018cites this paper
• ATP Evokes Ca2+ Responses and CXCL5 Secretion via P2X4 Receptor Activation in Human Monocyte-Derived Macrophages

  2018cites this paper
• Flavonoids and platelet-derived thrombotic disorders.

  2018cites this paper
• Medizintechnik

  2018cites this paper
• Global Trends in Aspirin Resistance‐Related Research from 1990 to 2015: A Bibliometric Analysis

  2017cites this paper
• Platelet distribution width as the prognostic marker in coronary bifurcation treatment

  2017cites this paper
• Chiral recognition of polysaccharide based CSP for separation of enantiomers and regio isomers of Prasugrel and its related impurities

  2017cites this paper
• SUMOylation regulates focal adhesions in cancer cell migration

  2017cites this paper
• Probing the interaction of a glycoprotein IIb/IIIa receptor antagonist with bound platelets using electrochemical impedance

  2017cites this paper
• Chapter 145 Antithrombotic and Thrombolytic Therapy

  2017cites this paper
• Aortic Aneurysms.

  2017cites this paper
• The Influence of CoCr L605 Induction to Blood Haemocompatibility

  2017cites this paper
• Studies on New Activities of Enantiomers of 2-(2-Hydroxypropanamido) Benzoic Acid: Antiplatelet Aggregation and Antithrombosis

  2017cites this paper
• Label-free detection of aggregated platelets in blood by machine-learning-aided optofluidic time-stretch microscopy.

  2017cites this paper
• Peptide therapeutics from venom: Current status and potential.

  2017cites this paper
• Arachidonic Acid Induced Thrombosis in Zebrafish Larvae for Assessing Human Anti-Thrombotic Drugs

  2017cites this paper
• 2015 Sheet 2 of 18 US 2015 / 0023975 A 1

  2017cites this paper
• Schisandra chinensis and Morus alba Synergistically Inhibit In Vivo Thrombus Formation and Platelet Aggregation by Impairing the Glycoprotein VI Pathway

  2017cites this paper
• Bioactive chemical constituents from the root bark of Morus australis.

  2017cites this paper
• Pathophysiology, causes and pharmacological study of arterial thrombosis

  2017cites this paper
• P2X4 receptor in human macrophages : role in ATP-evoked calcium responses and cytokine production

  2017cites this paper
• Platelet microparticles: a biomarker for recanalization in rtPA‐treated ischemic stroke patients

  2017cites this paper
• Antiplatelet and antithrombotic effects of cordycepin-enriched WIB-801CE from Cordyceps militaris ex vivo, in vivo, and in vitro

  2016cites this paper
• Aspirin Resistance in Different Doses by Bleeding Time and Urinary 11-dehydro-thromboxane B2.

  2016cites this paper
• Rapid characterization of hybridomas producing monoclonal antibodies against platelet β3 integrin using ELIspot

  2016cites this paper
• Capsaicin: Current Understanding of Its Mechanisms and Therapy of Pain and Other Pre-Clinical and Clinical Uses

  2016cites this paper
• Antithrombotic activities of ferulic acid via intracellular cyclic nucleotide signaling.

  2016cites this paper
• Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases.

  2016cites this paper
• ECMO Biocompatibility: Surface Coatings, Anticoagulation, and Coagulation Monitoring

  2016cites this paper
• Microfluidic Approaches to Thrombosis and Hemostasis: Towards a Patient-Specific Test of Antiplatelet Therapeutics and the Assessment of Coagulopathy in Hemophilic and Trauma Patients

  2016cites this paper
• In vitro and in vivo assessment of platelet function in healthy dogs during administration of a low-dose aspirin regimen.

  2016cites this paper
• Platelet function and ageing

  2016cites this paper
• Correlation between aspirin resistance and glycoprotein IIb HPA-3 polymorphism and recurrent ischemic stroke

  2016cites this paper
• A terapêutica antitrombótica: atual e em desenvolvimento

  2016cites this paper
• Hyperlipidemia, Disease Associations, and Top 10 Potential Drug Targets: A Network View

  2016cites this paper
• A novel thromboxane receptor antagonist, nstpbp5185, inhibits platelet aggregation and thrombus formation in animal models

  2016cites this paper
• Perioperative use of iloprost in cardiac surgery patients diagnosed with heparin‐induced thrombocytopenia‐reactive antibodies or with true HIT (HIT‐reactive antibodies plus thrombocytopenia): An 11‐year experience

  2015cites this paper
• DMD062596 510..522

  2015cites this paper
• Efficacy and Safety of Platelet Glycoprotein Receptor Blockade in Aged and Comorbid Mice With Acute Experimental Stroke

  2015cites this paper
• Physiologically Based Pharmacokinetic Modeling for Sequential Metabolism: Effect of CYP2C19 Genetic Polymorphism on Clopidogrel and Clopidogrel Active Metabolite Pharmacokinetics

  2015cites this paper
• New horizons in platelet research: Understanding and harnessing platelet functional diversity

  2015cites this paper
• Treatment of Acute ST-Elevation Myocardial Infarction

  2015cites this paper
• Privileged frameworks from snake venom

  2015cites this paper
• [Anti-platelets without a bleeding risk: novel targets and strategies].

  2015cites this paper
• BMI Affects the Relationship between Long Chain N-3 Polyunsaturated Fatty Acid Intake and Stroke Risk: a Meta-Analysis

  2015cites this paper
• Evaluation of various alloys for stent on platelet aggregation activity

  2015cites this paper
• L-Amino Acid Oxidase from Venoms

  2015cites this paper
• Antiplatelet drug resistance: Molecular insights and clinical implications.

  2015cites this paper
• Vipegitide: a folded peptidomimetic partial antagonist of α2β1 integrin with antiplatelet aggregation activity

  2015cites this paper
• Tyrosine kinase inhibitors modulate platelet function in vitro, ex vivo and in vivo

  2015cites this paper
• Prevalence of Aspirin Resistance in Patients with Ischemic Stroke at a Tertiary Care Center in North India

  2015cites this paper
• Aspirin resistance in children and young adults with splenectomized thalassemia diseases.

  2015cites this paper
• Association between polymorphisms of platelet membrane glycoprotein Ibα and risk of coronary heart disease in Han Chinese, Henan, China.

  2015cites this paper
• The inhibitory mechanism of crude saponin fraction from Korean Red Ginseng in collagen-induced platelet aggregation

  2015cites this paper
• N2 extenuates experimental ischemic stroke through platelet aggregation inhibition.

  2015cites this paper
• Current State and Novel Approaches of Antiplatelet Therapy

  2015cites this paper